MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The Value of Physician Assistant/Associates (PAs) in a Movement Disorder Clinic

    J. Karl, C. Cooper (Chicago, USA)

    Objective: To assess the value and productivity of physician assistants/associates (PA) in a movement disorder clinic. Background: Due to the aging population and shortage of…
  • 2023 International Congress

    Validation and replication of Parkinson disease behavioral subtypes

    C. Lessov-Schlaggar, P. Myers, J. Jackson, B. Maiti, P. Kotzbauer, J. Perlmutter, M. Campbell (St. Louis, USA)

    Objective: To validate and replicate clinical subtypes of Parkinson disease. Background: We recently identified three distinct clinical subtypes of Parkinson disease: motor (predominant motor with…
  • 2023 International Congress

    Effort-based decision-making and neuropsychiatric symptoms before and after subthalamic nucleus deep brain stimulation in Parkinson’s disease

    D. Amstutz, M. Sousa, K. Petermann, A. Botros, M. Maradan-Gachet, I. Debove, L. Lachenmayer, A. Diamantaras, J. Waskönig, C. Pollo, D. Cazzoli, T. Nef, M. Husain, P. Krack (Bern, Switzerland)

    Objective: Parkinson’s disease patients with apathy and patients in the medication OFF state show reduced reward sensitivity in effort-based decision-making tasks. The effect of subthalamic…
  • 2023 International Congress

    The neuroprotective properties of NLX-112 in MPTP treated mice are mediated by reactive gliosis and astrocytic GDNF

    W. Powell, A. Newman-Tancredi, L. Annett, R. Depoortere, M. Iravani (Hatfield, United Kingdom)

    Objective: To investigate whether NLX-112, a potent and selective 5-HT1A agonist is neuroprotective in a mouse MPTP model of Parkinson’s Disease (PD) [1]. Background: There…
  • 2023 International Congress

    Multiple N-of-1 trials to investigate hypoxia-based treatment in Parkinson’s disease: safety and short-term effects

    J. Janssen Daalen, M. Meinders, F. Giardina, S. Mathur, P. Ainslie, D. Thijssen, B. Bloem (Nijmegen, Netherlands)

    Objective: In this study, we describe the safety and short-term effects of the first hypoxia-based treatment trial in Parkinson’s disease by deploying a personalized multiple…
  • 2023 International Congress

    Combination COMT inhibitor with Levodopa reduces consumption of vitamin B6

    D. Kamiyama, N. Nishikawa, S. Ueno, C. Abe, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: To investigate changes in Levodopa (LD) pharmacokinetics and changes in homocysteine, vitamin B6, and vitamin B12 in Parkinson's disease (PD) patients receiving LD formulations…
  • 2023 International Congress

    The use of contrast-enhanced ultrasonography of muscle spasticity and myofascial trigger points

    R. Bubnov (Kyiv, Ukraine)

    Objective: The aim of this study was to evaluate the relevance of contrast-enhanced ultrasound (CEUS) for evaluating MTrPs vascularity and its potential added value for…
  • 2023 International Congress

    Intronic FGF14 GAA repeat expansions are a common cause of ataxia syndromes with neuropathy and bilateral vestibulopathy

    D. Pellerin, C. Wilke, A. Traschütz, S. Nagy, R. Currò, M-J. Dicaire, H. Garcia-Moreno, M. Anheim, T. Wirth, J. Faber, D. Timmann, C. Depienne, D. Rujescu, J. Gazulla, M. Reilly, P. Giunti, B. Brais, H. Houlden, L. Schöls, M. Strupp, A. Cortese, M. Synofzik (Montreal, Canada)

    Objective: To report on the frequency of intronic GAA expansions in the fibroblast growth factor 14 (FGF14) gene in patients with an unexplained cerebellar ataxia,…
  • 2023 International Congress

    Practices of neurologists in the management of Parkinson’s disease patients in the Republic of Moldova

    L. Rotaru, O. Grosu (Chisinau, Republic of Moldova)

    Objective: The aim of the study was to analyze practices of Moldovan neurologists regarding the management of Parkinson’s disease patients. Background: Parkinson’s disease management depends…
  • 2023 International Congress

    A retrospective comparison between EMG and US-guided botulinum injections for cervical dystonia

    V. Livneh, A. Socher, M. Cohen, Y. Schechter, I. Israel, T. Gurevic, G. Yahalom (Tel Aviv, Israel)

    Objective: To assess the efficacy and safety of ultrasound-guided (USg) botulinum toxin (BT) injections versus electromyography–guided (EMGg)- BT injections for cervical dystonia. Background: BT is…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley